Xeomin®, a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regenerati... | RTCL.TV
Channel: Medicine RTCL TV
Date: 2023-07-24

### Keywords ###
#botulinumneurotoxin #spinalcordinjury #regeneration #motorrecovery #sciaticstaticindex #neuropathicpain #RTCLTV #shorts

### Article Attribution ###
Title: Xeomin®, a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury
Authors: Valentina Mastrorilli, Federica De Angelis, Valentina Vacca, Flaminia Pavone, Siro Luvisetto ,and Sara Marinelli
Publisher: MDPI AG
DOI: 10.3390/toxins15040248
DOAJ URL: https://doaj.org/article/16fedbcc37d7426fa7f2dc724b21dd09
Source URL: https://www.mdpi.com/2072-6651/15/4/248



### Image Attribution ###
We used stable diffusion to programmatically generate the background images. 
Viewer discretion is advised.

### Channels ###
YouTube Channel: https://www.youtube.com/@medicinertcltv
Odysee Channel: https://odysee.com/@medicine_rtcl_tv

### Video Timestamps ###
0:00:00 - Summary 
0:00:51 - Title 
0:00:59 - End